Objective:
To investigate the
risk and
efficacy of the decortication in
treatment of
drug-resistant
tuberculous empyema.
Methods:
A retrospective
analysis was conducted on the 146
patients with
tuberculous empyema,
who underwent decortication in Wuhan Pulmonary
Hospital from March 2016 to November 2018, according to the
drug-susceptibility testing of the
pleural effusion or
tissue specimens, the
patients had been divided into
drug-resistant group(29 cases) and
control group(117 cases), compared the clinical datas such as operation
time, intraoperative
blood loss, postoperative drainage duration, pulmonary reexpansion duration,
postoperative complications and curative ratio between both groups, and the factors that influence the
risk and
efficacy of
surgery had been analyzed.
Results:
The
operative time, intraoperative
blood loss, postoperative drainage duration and
postoperative complications in the
drug-resistant group were larger than those in the
control group, and the differences were statistically significant ( P<0.05). There was no significant difference in pulmonary reexpansion duration and curative ratio in the two groups( P>0.05).
Conclusion:
Decortication is
safety, effective and feasible in the
treatment of
drug-resistant
tuberculous empyema, although the operation is difficult and risky.